Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 8Recruiting 6Unknown 3Withdrawn 1Terminated 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2CNS 1

Conditions

Brain Neoplasms 13Glioblastoma 6Glioma 5Epilepsy 5Stroke 3Pheochromocytoma 3Parkinson Disease 3Paraganglioma 3Neuroblastoma 3Neoplasms 3Speech 2Neurofibromatosis 1 2Neurofibroma 2Multiple Sclerosis 2Migraine Disorders 2Lung Neoplasms 2Diabetes Mellitus 2Carcinoma, Non-Small-Cell Lung 2Amyotrophic Lateral Sclerosis 2Adrenal Gland Neoplasms 2Tinnitus 1Thyroid Neoplasms 1Tension-Type Headache 1Stress Disorders, Post-Traumatic 1Squamous Cell Carcinoma of Head and Neck 1Spinal Stenosis 1Spinal Cord Injuries 1Skin Neoplasms 1Restless Legs Syndrome 1Renal Insufficiency, Chronic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Cognitive Dysfunction × CNS × Clear all
NCT02670161 2025-08-24

Quality Improvement and Practice Based Research in Neurology Using the EMR

Endeavor Health

Phase 4 Enrolling by invitation
3,300 enrolled
CNS

Brain Concussion, Brain Neoplasms, Epilepsy, Migraine Disorders, Multiple Sclerosis, Parkinson Disease, Restless Legs Syndrome, Stroke, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡